246 related articles for article (PubMed ID: 26307558)
1. A Prospective, Randomized, Single-Blinded, Head-to-Head Long-Term Outcome Study, Comparing Intrathecal (IT) Boluses With Continuous Infusion Trialing Techniques Prior to Implantation of Drug Delivery Systems (DDS) for the Treatment of Severe Intractable Chronic Nonmalignant Pain.
Hamza M; Doleys DM; Saleh IA; Medvedovsky A; Verdolin MH; Hamza M
Neuromodulation; 2015 Oct; 18(7):636-48; discussion 649. PubMed ID: 26307558
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
[TBL] [Abstract][Full Text] [Related]
3. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
Grider JS; Harned ME; Etscheidt MA
Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
[TBL] [Abstract][Full Text] [Related]
4. Trialing and Maintenance Dosing Using a Low-Dose Intrathecal Opioid Method for Chronic Nonmalignant Pain: A Prospective 36-Month Study.
Grider JS; Etscheidt MA; Harned ME; Lee J; Smith B; Lamar C; Bux A
Neuromodulation; 2016 Feb; 19(2):206-19. PubMed ID: 26477685
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal therapy for cancer and non-cancer pain.
Hayek SM; Deer TR; Pope JE; Panchal SJ; Patel VB
Pain Physician; 2011; 14(3):219-48. PubMed ID: 21587327
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Effects of Intermittent Boluses to Simple Continuous Infusion on Patients' Global Perceived Effect in Intrathecal Therapy for Pain: A Randomized Double-Blind Crossover Study.
Eldabe S; Duarte RV; Madzinga G; Batterham AM; Brookes ME; Gulve AP; Perruchoud C; Raphael JH; Lorenzana D; Buchser E
Pain Med; 2017 May; 18(5):924-931. PubMed ID: 27651513
[TBL] [Abstract][Full Text] [Related]
7. Continuous intrathecal meperidine via an implantable infusion pump for chronic, nonmalignant pain.
Harvey SC; O'Neil MG; Pope CA; Cuddy BG; Duc TA
Ann Pharmacother; 1997 Nov; 31(11):1306-8. PubMed ID: 9391683
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
Nitescu P; Dahm P; Appelgren L; Curelaru I
Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
10. Long-term intrathecal drug administration for chronic nonmalignant pain.
Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome and Adverse Events of Intrathecal Opioid Therapy for Nonmalignant Pain Syndrome.
Sommer B; Karageorgos N; AlSharif M; Stubbe H; Hans FJ
Pain Pract; 2020 Jan; 20(1):8-15. PubMed ID: 31291509
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
Kumar K; Kelly M; Pirlot T
Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Continuous Intrathecal Infusion Trialing with a Mixture of Fentanyl and Bupivacaine in Chronic Low Back Pain Patients.
Hayek SM; Jones BA; Veizi E; Tran TQ; DeLozier SJ
Pain Med; 2023 Jul; 24(7):796-808. PubMed ID: 36515491
[TBL] [Abstract][Full Text] [Related]
15. Implantable intrathecal pumps for chronic pain: highlights and updates.
Knight KH; Brand FM; Mchaourab AS; Veneziano G
Croat Med J; 2007 Feb; 48(1):22-34. PubMed ID: 17309136
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain.
Deer T; Chapple I; Classen A; Javery K; Stoker V; Tonder L; Burchiel K
Pain Med; 2004 Mar; 5(1):6-13. PubMed ID: 14996232
[TBL] [Abstract][Full Text] [Related]
17. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal drug therapy for long-term pain management.
Ghafoor VL; Epshteyn M; Carlson GH; Terhaar DM; Charry O; Phelps PK
Am J Health Syst Pharm; 2007 Dec; 64(23):2447-61. PubMed ID: 18029950
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
Du Pen S; Du Pen A; Hillyer J
Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
[TBL] [Abstract][Full Text] [Related]
20. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
Mitchell A; McGhie J; Owen M; McGinn G
Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
